Analysis of Changes in Medication Prescriptions After Hospitalization for 4 Disciplines: Gerontology, Diabetology, Cardiology and Rheumatology: Medical, Pharmaceutical and Economic Aspects

Diabetes Clinical Trial

— PHMEV  

Official title:

Analysis of Changes in Medication Prescriptions After Hospitalization for 4 Disciplines: Gerontology, Diabetology, Cardiology and Rheumatology: Medical, Pharmaceutical and Economic Aspects

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03371303
• Other study ID #: 2016-25
• Status: Active, not recruiting
• Phase: N/A
• First received: December 1, 2017
• Last updated: December 6, 2017
• Start date: November 1, 2017
• Est. completion date: February 2021

Study information

• Verified date: December 2017
• Source: Assistance Publique Hopitaux De Marseille
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The modifications of the medicinal treatments secondary to the hospitalizations have multiple reasons: reassessment of the previous treatment (conciliation), new therapeutic necessities, potential risk of iatrogeny or of drug interaction, restrictions of the therapeutic booklet, classification in reserve or hospital prescription ... These modifications are potentially generating extra costs for the Health Insurance and are monitored under the terms of the Contract of Good Use. The aims of this analysis are to define the medical-pharmaceutical rationale of the treatment changes imposed by hospitalization in a university-hospital center, their influence on the security of the medical treatment of patients and their financial implications for healthcare organizations

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 400
• Est. completion date: February 2021
• Est. primary completion date: February 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

inclusion criteria

• Patient social insured

• Patient belonging to the general social security scheme

• Patient followed in cardiology, rheumatology, geriatrics or diabetology departments

no exclusion criteria

Related Conditions & MeSH terms

• Cardiac Disease
• Collagen Diseases
• Diabetes
• Heart Diseases
• Rheumatic Diseases

Intervention

Other:
• collection of prescription data
collection of prescription data before and after a hospitalization

Locations

Country	Name	City	State
France	Assistance Publique Hôpitaux de Marseille	Marseille

Sponsors (1)

Lead Sponsor	Collaborator
Assistance Publique Hopitaux De Marseille

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	entry orders before hospitalization		15 months
Primary	exit orders after hospitalization		15 months